Protocol No.: CA057-008

A Phase 3, Two-stage, Randomized, Multicenter, Open-label Study Comparing CC-92480 (BMS-986348), Carfilzomib, and Dexamethasone (480Kd) Versus Carfilzomib and Dexamethasone (Kd) in Participants with Relapsed or Refractory Multiple Myeloma (RRMM)
Principal Investigator
Safi, Salah Ud Din
Phase
III
Age Group
Adult
Applicable Disease Site
Multiple Myeloma
Participating Institution
Mary Babb Randolph Cancer Center
Contact
Kristin Volk, RN
Research Nurse
Phone: +1 304-581-1893

View on ClinicalTrials.gov